Return Home

about IAS-USA
news and events
cme programs
course registration
Cases on the Web
publications/guidelines
guidelines
Pocket Cards
Webcast and Podcasts
board and staff
core faculty
fdd
donations
contact
home


FACULTY


Fred R. Sattler, MD
Professor of Medicine and Biokinesiology
University of Southern California School of Medicine
Division of Infectious Diseases
Department of Medicine
Director of HIV Research
Rand Shrader Clinic
Los Angeles County-University of Southern California Medical Center
Los Angeles, CA

Research, Lecture, and Writing Topics
  • Anabolic interventions for muscle wasting
  • Aerobic and resistance exercise in health and disease
  • Lipid and adipose tissue dysregulation


Current Professional Summary

Dr Sattler is Associate Program Director at the University of Southern California General Clinical Research Center and Director of HIV Research at the Rand Shrader Clinic of the University of Southern California Medical Center.


Committees and Organizations

  • Chairman, Keck School of Medicine Appointment, Promotion and Tenure Committee
  • Member, NIH AARR-6 Study Section


Honors and Awards
  • Phi Beta Kappa, UCLA Cum Laude


Education
  • University of California Los Angeles, BS Chemistry (1969)
  • University of Southern California, MD (1973)
  • Stanford University, Post-Doctoral Fellowship in Infectious Diseases (1979)


Selected Publications
  1. Sattler FR, Briggs W, Antonipillai I, Allen J, Horton R. Low dihydrotestosterone and weight loss in the AIDS wasting syndrome. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:246-251.
  2. Sinha-Hikim I, Arver S, Beall G, Ruoqing S, Guerrero M, Sattler FR, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S. The use of a sensitive equilibrium dialysis method for the the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus infected women. J Clin Endocrinol Metab. 1998;83:1312-1318.
  3. Rivera S, Briggs W, Qian D, Sattler FR. Levels of RNA are quantitatively related to prior weight loss in HIV associated wasting. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:411-418.
  4. Moldawer LL, Sattler FR. Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation. Sem in Oncol. 1998;25(suppl 1):73-81.
  5. Afghani A, Jaque SV, Shroeder ET, Olson C, Dube M, Sattler FR. Resistance training alters kinetics of body composition adaptations to anabolic agents in HIV positive men. In: Proceedings of Southwest American College of Sports Medicine Conference. Abstract 4, Las Vegas, Nev; November 13-14, 1998.
  6. Dube MP, Sattler FR. Metabolic complications of antiretroviral therapy. AIDS Clin Care. 1998;10:41-44.
  7. Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen SP. Effects of pharmacologic doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with HIV. J Clin Endocrinol Metab. 1999;84:1268-1272.
  8. Rivera S, Sattler FR, Olson C, Qian D, Briggs W, Bhasin S, Horton R. Block in the generation of dihydrotestosterone from testosterone in patients with weight loss. In: Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Abstract 701. Chicago, Ill; January 31-February 4, 1999.
  9. Schroeder ET, Jaque SV, Afghani A, Hawkins SA, Olson C, Wiswell RA, Sattler FR. Comparison of regional DEXA and MRI assessment of mass and strength gains. Med Sci Exercise. 1999;31(suppl):5.
  10. Johnson DL, Sattler FR, Qian D, Briggs W, Louie S, Dube MP. Hypertension in patients with metabolic dysregulation. In: Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. Abstract 23. San Francisco, Calif; January 31-February 4, 2000.

Return to Top



© Copyright 2012. International Antiviral Society–USA. All rights reserved.
Use of this site is subject to the Visitor's Agreement and Privacy and Confidentiality Policy.
Please read them carefully.